stockrowEmergent Biosolutions Inc. (EBS) vs Kamada Ltd. (KMDA)
- Emergent Biosolutions Inc. EBS 5.92 +0.34%
- Kamada Ltd. KMDA 6.89 −7.14%
Emergent Biosolutions Inc. and Kamada Ltd. are both Drug Manufacturers Specialty & Generic companies. Kamada Ltd. is the larger, with a market value of $396.3M against $300.8M — 1.3× the size. Emergent Biosolutions Inc. has negative trailing earnings, so its P/E is not meaningful; Kamada Ltd. trades at 18.1×. Kamada Ltd. grew revenue faster over the last twelve months: 13.2% against −17.7%. Kamada Ltd. has the higher net margin (11.6% vs −40.2%) and the higher return on invested capital (8.47% vs −17.5%). Across the 20 metrics below, Kamada Ltd. leads on 11 and Emergent Biosolutions Inc. on 9.
Valuation
Profitability
| Metric | EBS | KMDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 48.42% | 40.82% | 53.51% |
| Operating margin | (27.70%) | 14.51% | 0.00% |
| Net margin | (40.16%) | 11.60% | (2.45%) |
| Free cash flow margin | 29.89% | 13.72% | 0.00% |
| Return on equity | (58.21%) | 8.40% | (0.80%) |
| Return on assets | (21.23%) | 5.92% | (1.67%) |
| Return on invested capital | (17.45%) | 8.47% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack